Experimental Immune Reset Puts Lupus Into Remission

After three decades of battling lupus so severe she couldn't lift a cup of tea, Katie Tinkler is now climbing mountains and planning adventures. An experimental immune system reset has freed her from a disease that once left her unable to walk with her children.

Katie was diagnosed with lupus in 1993 at age 20. The autoimmune disease causes the body to attack itself, triggering joint pain, organ damage, and debilitating flares that kept her bedridden for days.

For years, she carried emergency steroids everywhere and needed medication 45 minutes before getting out of bed just to manage the pain. Despite working as a fitness instructor, she lived on the edge of crisis.

The disease turned aggressive in the past decade. Her lupus damaged her heart, lungs, and kidneys so badly she was approaching dialysis.

Then came an experimental treatment at University College London Hospitals that changed everything. Scientists removed millions of Katie's T cells and genetically modified them to attack the rogue B cells causing her lupus.

The engineered cells waged war inside her body, destroying both diseased and healthy B cells. Months later, fresh healthy cells grew back, effectively rebooting her immune system.

The treatment was risky. Katie signed papers acknowledging she could die, and the process included chemotherapy to prevent rejection.

But 18 months after her November 2024 treatment, Katie is medication-free. Her organs have recovered, and she's been skiing for the first time in a decade.

Why This Inspires

Five of the first six patients treated remain in remission after more than 18 months. The approach, called CAR-T therapy, is already approved for blood cancers and could revolutionize treatment for multiple sclerosis, rheumatoid arthritis, and other autoimmune diseases that affect millions.

Dr. Maria Leandro from UCLH calls it "a significant step forward towards a possible cure." Clinical trials are already underway for multiple sclerosis.

The treatment doesn't guarantee permanent remission. Doctors don't yet know how long the effects will last or how it will perform in larger trials.

But for Katie, every day feels like borrowed time worth celebrating. She's planning to climb Kilimanjaro and complete another triathlon, saying yes to every opportunity.

"I sort of forgot that you could feel this good," she says, living fully for the first time since her diagnosis 30 years ago.